Synthesis of 3′-Deoxy-3′ -[4-(pyrimidin-1-yl)methyl-1,2,3-triazol-1-yl]thymidine via 1,3-Dipolar Cycloaddition

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 11, 2003, Pages 1985-1993

  Tourirte, M ^a   Oulih, T ^b   Lazrek, H B ^b   Barascut, J L ^c   Imbach, J L ^c   Almasoudi, N A ^d  

^a FACULTÉ DES SCIENCES ET TECHNIQUES GUÉLIZ   (Morocco)

^b FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^c CNRS   (France)

^d UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

1,2,3 Triazole; 1,3 Dipolar cycloaddition; Propargylpyrimidine

Indexed keywords

3' AZIDO 3' DEOXY 5' O MONOMETHOXYTRITYL THYMIDINE; 3' DEOXY 3' [4 (BROMOURACIL 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; 3' DEOXY 3' [4 (CHLOROURACIL 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; 3' DEOXY 3' [4 (FLUOROURACIL 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; 3' DEOXY 3' [4 (IODOURACIL 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; 3' DEOXY 3' [4 (THYMIN 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; 3' DEOXY 3' [4 (URACIL 1 YLMETHYL) 1,2,3 TRIAZOL 1 YL]THYMIDINE; PYRIMIDINE DERIVATIVE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DRUG DERIVATIVE; THIAZOLE DERIVATIVE; THYMIDINE;

ARTICLE; CHEMICAL PROCEDURES; CYCLOADDITION; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INHIBITION KINETICS; PROTECTION; VIRUS REPLICATION; CELL LINE; CHEMISTRY; CYCLIZATION; HUMAN; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ANTI-HIV AGENTS; CELL LINE; CYCLIZATION; HIV-1; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; THYMIDINE;

EID: 0345283269     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120026399     Document Type: Article

References (24)

1. 3 phosphorous atom. J. Med. Chem. 1990, 33, 572-576.
2. Wigerinck, P.; Van Aerschot, A.; Claes, P.; Balzarini, J.; De Clercq, E. ; Herdewijn, P. 3′-(1,2,3-Triazol-1-yl)-2′,3′- dideoxythymidine and 3′-(1,2,3-triazol-1-yl)-2′,3′ -dideoxyuridine. J. Heterocycl. Chem. 1989, 26, 1635-1642.
3. Häbich, D.; Barth, W.; Rösner, M. Synthesis of 3′-(1,2,3-triazol-1-yl)-3′-deoxythymidines. Heterocycle 1989, 29, 2083-2087.
4. Wigerink, P.; Van Aerschot, A.; Janssen, G.; Claes, P.; Balzarini, J.; De Clercq, E.; Herdewijn, P. Synthesis and antiviral activity of 3′-heterocyclic substituted 3′-deoxythymidines. J. Med. Chem. 1990, 33, 868-873.
5. Pannecouque, C.; Busson, R.; Balzarini, J.; Claes, P.; De Clercq, E.; Herdewijn, P. Synthesis and antiviral evaluation of 3′-substituted thymidine analogues derived from 3′-amino-3′-deoxythymidine. Tetrahedron 1995, 51, 5369-5380.
6. Radi, S.; Lazrek, H.B. Synthesis and biological activity of new 1,2,3-triazole acyclonucleosides analogues of ACV. J. Chem. Research (S) 2002, 6, 264-266.
7. Moukha-Chafiq, O.; Taha, M.L.; Lazrek, H.B.; Vasseur, J.J.; Pannecouque, C.; Witrouw, M.; De Clercq, E. Synthesis and biological activity of some 4-substituted 1-[1-(2,3-dihydroxy-1-propoxy)-1,2,3-triazol-(4& 5)-ylmethyl]-lH-pyrazolo[3,4d]pyrimidines. IL Farmaco 2002, 57, 27-32, and references cited therein.
8. [10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells. J. Org. Chem. 2001, 66, 5655-5663.
9. Carruthers, W. Cycloaddition Reaction in Organic Synthesis; Pergamon Press: New York, 1990; 269-331.
10. Al-Masoudi, N.A.; Al-Soud, Y.A. New glycosyl-(carboxamide)-1,2,3-triazole-N-nucleosides: Synthesis and antitumor activity. Nucleosides & Nucleotides and Nucleic Acids 2002, 21, 361-375, and references cited therein.
11. Lin, T.-S.; Fschinazy, R.; Pursoff, W.H. Potent and selective in vitro activity of 3′-deoxythymidin-2′-ene-(3′-deoxy-2′ ,3′-didehydrothymidine) against human immunodeficiency virus. Biochem. Pharmacol. 1987, 36, 2713-2718.
12. Lazrek, H.B.; Taourirte, M.; Oulih, T.; Barascut, J.L.; Imbach, J.L.; Pannecouque, C.; Witrouw, M.; De Clercq, E. Synthesis and anti-HIV activity of new modified 1,2,3-triazole acyclonucleosides. Nucleosides & Nucleotides and Nucleic Acids 2001, 20, 1949-1960.
13. Horwitz, J.P.; Chua, J.; Noel, M. Nucleosides. V. The monomesylates of 1-(2-deoxy-β-D-lyxofuranosyl)thymidine. J. Org. Chem. 1964, 29, 2076-2078.
14. Yamamoto, I.; Sekine, M.; Hata, T. One-step synthesis of 5-azido nucleosides. J. Chem. Soc. Perkin I 1980, 306-310.
15. L'abbé, G.; Hassner, A. Regiochemistry in cycloaddition reactions of vinyl azides with phenylacetylene. Bull. Soc. Chim. Belg. 1971, 80, 209-210.
16. L'abbé, G.; Galle, J.E.; Hassner, A. Cycloaddition reactions of vinyl azides and β-iodo azides with acetylene esters. Tetrahedron Lett. 1970, 303-306.
17. Elguero, J.; Gonzàlez, E.; Jacquier, R. Research in the azole series. XXVI. Nuclear magnetic resonance study and the reaction of 1,2,3-triazole with halo nitrobenzenes. Bull. Soc. Chim. France 1967, 2998-3003.
18. Alonso, G.; Garcia-Lôpez, M.T.; Garcia-Munoz, G.; Madronero, R.; Rico, M. N-Glycosides. VI. The reaction of glycosyl azides with propiolic acid and methyl propiolate. J. Heterocycl. Chem. 1970, 7, 1269-1272.
19. Alonso, R.; Camarasa, M.J.; Alonso, G.; De Las Heras, F.G. Alkylating nucleosides. V. Synthesis and cytostatic activity of N-ribosyl-halomethyl-1,2,3-triazoles. Eur. J. Med. Chem. 1980, 15, 105-109.
20. Alvarez, R.; Velàzquez, S.; San-Félix, A.; Aquaro, S.; De Clércq, E.; Perno, C.-F.; Karlsson, A.; Balzarini, J.; Camarasa, M.J. 1,2,3-Triazole-[2′,5′-bis-O-(tert-butyldimethylsilyl) -β-D-ribofuranosyl]-3′-spiro-5″-(4″-amino-l″, 2″-oxathiole 2″,2″-dioxide) (TSAO) analogues: Synthesis and anti-HIV-1 avtivity. J. Med. Chem. 1994, 37, 4185-4194.
21. Garcia-Lopez, M.T.; Garcia-Munoz, G.; Iglesias, J.; Madronero, R. Heterocylic N-glycosides. III. Synthesis of N-glycosyl-v-triazoles from glycosyl azides and phenylacetylene. J. Heterocycl. Chem. 1969, 6, 639-642.
22. De Las Heras, F.G.; Alonso, R.; Alonso, G. Alkylating nucleosides I. Synthesis and cytostatic activity of N-glycosyl-(halomethyl)-1,2,3-triazoles. A new type of alkylating agent. J. Med. Chem. 1979, 22, 496-500.
23. a) Pauwels, R.; Balzarini, J.; Baba, H.; Snoeck; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 1988, 20, 309-321;
24. Witvrouw, M.; Balzarini, J.; Pannecouque, C.; Ihaumeer-Laulloo, S.; Est, J.; Schols, D.; Cherepanov, P.; Schmit, J.-C.; Deyser, Z.; Vandamme A.-M.; Desmyter, J.; De Clercq, E. SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus. Antimicrob. Agents Chemother. 1997, 41, 262-268.